News

• OMIC Publishes Sample Notification Letter and Phone Script About Compounded Drugs
  

  The FDA requests ophthalmologists notify patients who received injectable medications such as Avastin or Kenalog, or medications in conjunction with eye surgery, that were compounded by the New England Compounding Center (NECC). OMIC has prepared a sample notification letter.Please review it and make any changes you feel are necessary. Please consider sending this letter to […]

• Updated Requirements for Securing Protected Patient Information Published By HHS
  

    The U.S. Department of Health and Human Services (HHS) has published a new protocol that is being used to audit health care entities for compliance with the Health Information Portability and Accountability Act (HIPAA). The protocol provides guidance for physicians to meet HIPAA requirements to secure protected electronic health information. HHS is conducting audits […]

• OMIC Forms 42nd Educational Alliance with the Michigan Society of Eye Physicians and Surgeons (MiSEPS)
  

  This cooperative venture will significantly reduce malpractice premiums for MiSEPS members by offering a 10% discount (averaging more than $1,300) to members for attending a qualifying cosponsored risk management event. CME credit available for some courses. For more information on OMIC’s CV program contact Deena Mader at OMIC at 800-562-6642, ext. 628. www.omic.com . To read more […]

• OMIC Publishes New Keratoprosthesis Consent Form
  

  OMIC has posted a new consent form for Keratoprosthesis! See it in Clinical Issues: Cornea and Drugs and Devices and also in Consent Forms.